StockpollyBeta
Get App
Popularity #693
OLN · NYSE · Chemicals

Olin (OLN)

Manufactures chlorine-chain chemicals, epoxies and Winchester ammunition.

$16.96
vs last close+0.41 (+2.51%)
Loading prices…

Something off on this page? Send us feedback.

Olin CorporationOLN
Materials

Manufactures and sells chlorine-chain chemicals, vinyls and epoxies alongside Winchester ammunition. The vertically integrated chemical operation and U.S. ammunition franchise were expanded by the Dow chlorine-business transaction.

Produces chlorine and caustic soda, vinyls, chlorinated organics and epoxies, alongside Winchester ammunition. The chemical business also includes bleach and hydrochloric acid; Winchester produces sporting, law-enforcement, reloading, small-caliber military and industrial ammunition products. Winchester's range includes both sporting products and small-caliber military ammunition.

A vertically integrated global chemical operation sits alongside U.S. ammunition manufacturing. The addition of Dow's chlorine, vinyl, chlorinated-organics and epoxy businesses expanded the chemicals portfolio; the Mathieson merger and Winchester acquisition underpin its current shape. A proposed all-stock combination with Huntsman remains pending shareholder and regulatory approvals.

Company facts

CEOKenneth T. Lane
ListedDec 30, 1987
ExchangeNYSE
HeadquartersClayton, MO
CountryUnited States
Employees7,849
CIK0000074303
ISINUS6806652052

Market cap$1.89B
EPS (ttm)−$1.23
P/E (ttm)−13.45
ROE-7.7%
P/B1.10
P/S0.2812
Dividend yieldDiv yield4.84%
Beta0.76vs XLB 1.74

Price target$21.00+27.0%Average of 35 analysts
ConsensusHold22 of 35 analysts
Ratings

Target rangeAs of Sep 21, 2026

Latest analyst notes

DateFirmActionPriorCurrent
Sep 11, 2026KeyBancInitiate
Rating: —
Rating: Overweight
Aug 25, 2026Deutsche BankReiterate
Rating: —Target: $26
Rating: HoldTarget: $20
Aug 4, 2026Goldman SachsReiterate
Rating: —Target: $24
Rating: NeutralTarget: $20
Aug 4, 2026Wells FargoDowngrade
Rating: Overweight
Rating: Equal Weight
Aug 3, 2026Wells FargoTarget
Target: $37
Target: $20

Next report
Oct 26, 26
in 34 days
EPS estimate
$0.18
Revenue estimate
$1.85B
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Jan '25May '25Jul '25Oct '25Jan '26May '26Jul '26Oct '26
Reported$0.09$0.04$0.05$0.40−$0.58−$0.65$0.07Pending
Estimate−$0.01−$0.10$0.10$0.08−$0.64−$0.67$0.07$0.18
Surprise+1,000.0%+140.0%−50.5%+426.9%+9.2%+3.0%0.0%—

RevenueReportedEstimate

Jan '25May '25Jul '25Oct '25Jan '26May '26Jul '26Oct '26
Reported$1.67B$1.64B$1.76B$1.71B$1.67B$1.58B$1.74BPending
Estimate$1.55B$1.58B$1.74B$1.73B$1.54B$1.62B$1.81B$1.85B
Surprise+8.2%+4.4%+0.8%−1.2%+8.2%−2.3%−3.5%—
Estimate$0.18
ReportedDue Oct 26, 2026
Estimate$1.85B
ReportedDue Oct 26, 2026
View details

Debt to equity199.10%
Current ratio141.80%

ProfitabilityRevenueNet incomeNet margin

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue$1.59B$1.67B$1.64B$1.76B$1.71B$1.67B$1.58B$1.74B
Net income−$24.9M$10.7M$1.4M−$1.3M$43.0M−$85.7M−$83.0M−$13.3M
Net margin0.0%0.6%0.1%0.0%2.5%0.0%0.0%0.0%

GrowthOperating income

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Operating income$15.5M$47.3M$43.7M$35.3M$400.0K−$62.7M−$69.2M$46.5M
YoY growth−90.7%−52.2%−55.1%−74.1%−97.4%Turned lossTurned loss+31.7%

Balance sheet, Jun 30, 2026Cash & short-term investments $177.4M · Total debt $3.41B · Total assets $7.44B · Shareholders' equity $1.71B

Revenue
$1.74B
Operating income
$46.5M
Net income
−$13.3M
View details

Dividend yield
4.84%
Next ex-date
Nov 27, 26
estimated · in 66 days
Annual dividend
$0.80
per share
Schedule
Quarterly
4 payments a year

HistoryDividendAnnual yield

Nov '24Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26
Dividend$0.20$0.20$0.20$0.20$0.20$0.20$0.20$0.20
Annual yield1.91%3.22%3.79%3.50%3.79%3.29%2.88%4.63%
Ex-dateNov 14Mar 6May 15Aug 28Nov 28Mar 3May 14Aug 27
Payment dateDec 13Mar 14Jun 13Sep 12Dec 12Mar 13Jun 12Sep 11
View details

Institutions≈ 100.46%114.51M shares
431 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail
Insiders0.22%252.9K shares
12 holders · as of Jun 18, 2026
Adds to100.68%

113.98M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.

These groups come from separate filings that can overlap, so they add to 100.68%; nothing is left for Other.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
Hotchkis & Wiley Capital Management LLCInstitution
14.06%16.02Mas of Jun 30, 2026
Hotchkis and Wiley Capital Management, LLCInstitution
13.40%15.28Mfiled Feb 17, 2026
BlackRock, Inc.Institution
10.51%11.98Mas of Jun 30, 2026
Dimensional Fund Advisors LPInstitution
5.41%6.17Mas of Jun 30, 2026
AQR Capital Management LLCInstitution
4.83%5.51Mas of Jun 30, 2026

Insider tradesForm 4

DateInsiderRoleSharesAvg price
Feb 25, 2026Deon Carterofficer: VP & President CAPV−6,500$23.73
Feb 24, 2026Angela M. Castleofficer: VP & Chief Legal Officer−2,379$24.25
Feb 3, 2026Todd A. Slaterofficer: VP & CFO−92,250$22.48
Feb 3, 2026R. Nichole Sumnerofficer: VP & Controller−4,750$22.49
Nov 26, 2025Teresa M. Vermillionofficer: VP & Treasurer−4,500$20.86
View details

  • Westlake

    Chlor-alkali, vinyls, and epoxy overlap across core chemical markets

  • Occidental Petroleum

    Chlor-alkali and vinyls overlap in North American commodity chemicals

  • Huntsman

    Epoxy materials overlap; announced combination remains pending

  • General Dynamics

    Small-caliber military ammunition overlaps with Winchester programs

Compare

CompanyPriceChange
Olin$16.96+2.51%$1.89B—52.30.3−0.9%
Westlake$69.35+2.33%$8.68B—18.90.8+10.8%
Occidental Petroleum$56.98−0.47%$56.94B8.812.22.3+25.7%
Huntsman$9.12+2.88%$1.55B—239.30.3+14.1%
General Dynamics$343.76−2.87%$95.75B21.619.71.7+8.1%
Median15.219.31.3+12.4%